Your browser doesn't support javascript.
loading
Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).
Stahler, A; Heinemann, V; Giessen-Jung, C; Crispin, A; Schalhorn, A; Stintzing, S; Fischer von Weikersthal, L; Vehling-Kaiser, U; Stauch, M; Quietzsch, D; Held, S; von Einem, J C; Holch, J; Neumann, J; Kirchner, T; Jung, A; Modest, D P.
Affiliation
  • Stahler A; Department of Medicine III And Comprehensive Cancer Centre, University Hospital Grosshadern, University of Munich, Germany.
  • Heinemann V; Institute of Pathology, University of Munich, Germany.
  • Giessen-Jung C; Department of Medicine III And Comprehensive Cancer Centre, University Hospital Grosshadern, University of Munich, Germany.
  • Crispin A; DKTK, German Cancer Consortium, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Schalhorn A; Department of Medicine III And Comprehensive Cancer Centre, University Hospital Grosshadern, University of Munich, Germany.
  • Stintzing S; Institute of Medical Informatics, Biometry, and Epidemiology, University of Munich, Germany.
  • Fischer von Weikersthal L; Department of Medicine III And Comprehensive Cancer Centre, University Hospital Grosshadern, University of Munich, Germany.
  • Vehling-Kaiser U; Department of Medicine III And Comprehensive Cancer Centre, University Hospital Grosshadern, University of Munich, Germany.
  • Stauch M; DKTK, German Cancer Consortium, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Quietzsch D; Klinikum St. Marien, Oncology, Amberg, Germany.
  • Held S; Onkologische Praxis, Landshut, Germany.
  • von Einem JC; Onkologische Schwerpunktpraxis in Kronach, Ambulantes Zentrum Für Hämatologie Und Onkologie, Kronach, Germany.
  • Holch J; Klinikum Chemnitz, Chemnitz, Germany.
  • Neumann J; ClinAssess GmbH, Leverkusen, Germany.
  • Kirchner T; Department of Medicine III And Comprehensive Cancer Centre, University Hospital Grosshadern, University of Munich, Germany.
  • Jung A; Department of Medicine III And Comprehensive Cancer Centre, University Hospital Grosshadern, University of Munich, Germany.
  • Modest DP; Institute of Pathology, University of Munich, Germany.
Int J Cancer ; 138(3): 739-46, 2016 Feb 01.
Article in En | MEDLINE | ID: mdl-26284333

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Amphiregulin / Epiregulin Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2016 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Amphiregulin / Epiregulin Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2016 Type: Article Affiliation country: Germany